Quantitative pathology scoring confirmed markedly lower injury in the 4-H1-anti-HSA-4-H1 treated group (Fig. 7C), with significantly reduced alveolitis and interstitial pneumonia (Fig. 7D and E). Here, ALB is linked to hypersensitivity pneumonitis.